We offer a wide range of support and services to market access and HEOR teams from global to local level, including: evidence and market access strategy development; the generation and assimilation of evidence; and implementation and communication to payers and other stakeholders. Our team of in-house market access consultants, health economists, writers, analysts and developers are experienced and skilled, and ready to help you with your latest market access challenge. We have access to a broad network of payers, clinicians and other stakeholders across global markets, who we regularly engage to inform our insights and recommendations.
A robust, comprehensive evidence base is crucial in demonstrating the effectiveness and, ultimately, the value of your product to payers and other key stakeholders. Our team of market access experts and evidence-based scientists will support you in understanding the evidence needed to achieve success, and in the planning, execution and implementation of evidence generation activities to support your access strategy.
In a highly dynamic and evolving global healthcare environment, demonstrating the value of your product is key to ensuring patient access and achieving commercial success. Our experts will support you in understanding the market landscape and value of your product, and in developing robust value, market access and pricing strategies, as well as developing and validating value propositions.
It is essential to communicate the clinical and economic value of your product in a way that resonates with the many stakeholders in access and reimbursement decision-making. Our consultants and communication experts will guide you through reimbursement and health technology assessment (HTA) submissions process, where evidence and value determine access decisions. Our health economic modellers will quantify the financial benefits of product adoption, and our experienced digital team are world-leaders in developing engaging, interactive value communication tools for use with payers and clinicians.
At Mtech Access we are always striving to engage with the wider market access community and share our thoughts on the latest industry issues or methods development.
